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Abstract
The incidence of extended-spectrum b-lactamases (ESBLs) has been increasing worldwide, but screening criteria for
detection of ESBLs are not standardized for AmpC-producing Enterobacteriaceae such as Enterobacter species. In this study,
we investigated the prevalence of ESBLs and/or AmpC b-lactamases in Japanese clinical isolates of Enterobacter spp. and the
association of plasmid-mediated quinolone resistance (PMQR) determinants with ESBL producers. A total of 364 clinical
isolates of Enterobacter spp. collected throughout Japan between November 2009 and January 2010 were studied. ESBL-
producing strains were assessed by the CLSI confirmatory test and the boronic acid disk test. PCR and sequencing were
performed to detect CTX-M, TEM, and SHV type ESBLs and PMQR determinants. For ESBL-producing Enterobacter spp.,
pulsed-field gel electrophoresis (PFGE) was performed using XbaI restriction enzyme. Of the 364 isolates, 22 (6.0%) were
ESBL producers. Seven isolates of Enterobacter cloacae produced CTX-M-3, followed by two isolates producing SHV-12. Two
isolates of Enterobacter aerogenes produced CTX-M-2. Of the 22 ESBL producers, 21 had the AmpC enzyme, and six met the
criteria for ESBL production in the boronic acid test. We found a significant association of qnrS with CTX-M-3-producing E.
cloacae. The 11 ESBL-producing Enterobacter spp. possessing blaCTX-M, blaSHV,o rblaTEM were divided into six unique PFGE
types. This is the first report about the prevalence of qnr determinants among ESBL-producing Enterobacter spp. from Japan.
Our results suggest that ESBL-producing Enterobacter spp. with qnr determinants are spreading in Japan.
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Introduction
Enterobacter species are an important opportunistic pathogen that
can cause nosocomial outbreaks and invasive infections such as
bloodstream infections [1–3]. The prevalence of Enterobacteria-
ceae with extended-spectrum b-lactamases (ESBLs) has been
increasing worldwide [4]. The prevalence of ESBLs and/or AmpC
b-lactamases in clinical isolates of Enterobacter spp. from Japan is
unknown. The Clinical and Laboratory Standards Institute (CLSI)
has established guidelines for detection of ESBLs in Escherichia coli,
Klebsiella spp., and Proteus mirabilis [5]. However, there are no
recommendations from the CLSI for detection of ESBLs in
microorganisms with chromosomal AmpC b-lactamases since the
presence of ESBLs can be masked by the AmpC b-lactamases. It
has been reported that 3-aminophenylboronic acid (BA) is an
inhibitor of AmpC [6], and it is possible to detect ESBLs in
AmpC-producing strains by the boronic acid disk test [7].
Quinolone resistance was mainly caused by chromosomal
mutations of the quinolone-resistance determining regions in
DNA gyrase and DNA topoisomerase IV [8,9]. Recently, plasmid-
mediated quinolone resistance (PMQR) determinants such as qnr,
aac(69)-Ib-cr, and qepA, have been identified in clinical isolates of
Enterobacteriaceae worldwide [8,9]. In addition, the emergence of
PMQR in ESBL-producing Enterobacteriaceae is raising public
health concerns since the inappropriate use of antimicrobial agents
can transfer PMQR genes on the same plasmid as b-lactamase
genes [8].
In this study, we investigated the prevalence of ESBLs and/or
AmpC b-lactamases in clinical isolates of Enterobacter spp. from
Japan and the association of PMQR determinants with ESBL-
producing isolates. We also evaluated the usefulness of the boronic
acid disk test for detecting production of ESBLs by Enterobacter spp.
This work was presented in part at the 50th Interscience
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Materials and Methods
Bacterial Strains
We studied a total of 364 consecutive and nonduplicate clinical
isolates of Enterobacter spp., consisting of 228 isolates of Enterobacter
cloacae and 136 isolates of Enterobacter aerogenes. These isolates were
collected between November 2009 and January 2010 from 10
regions of Japan, including 38 isolates from Hokkaido, 13 from
Miyagi, 19 from Niigata, 95 from Tokyo, 7 from Aichi, 50 from
Osaka, 15 from Hiroshima, 10 from Ehime, 99 from Fukuoka, and
18 from Okinawa. Enterobacter spp. were identified by the Vitek-2
System (Sysmex-bioMe ´rieux Japan, Tokyo). The isolates included
115 from urine (31.6%), 95 from sputum (26.1%), 77 from throat
swabs (21.2%), 26 from nasal (7.1%), and 51 from other specimens
(14.0%). Ethical approval was not needed according to the ethical
guidelines for epidemiological research by the Japanese govern-
ment because this study focused on bacterial aspects.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing of ESBL-producing isolates
was performed with a frozen plate (Eiken Chemical Co., Ltd.,
Tokyo, Japan) and the broth microdilution method described by
the CLSI [10]. The following antimicrobial agents were tested:
ampicillin (range: 1–32 mg/L), piperacillin (4–128 mg/L), piper-
acillin-tazobactam (4/4–128/4 mg/L), cefoxitin (1–32 mg/L),
cefpodoxime (2–64 mg/L), cefotaxime (2–64 mg/L), ceftazidime
(2–64 mg/L), cefepime (1–32 mg/L), meropenem (0.5–16 mg/L),
aztreonam (1–32 mg/L), ciprofloxacin (0.5–16 mg/L), levoflox-
acin (0.5–16 mg/L), gentamicin (1–16 mg/L), amikacin (8–
64 mg/L), and trimethoprim-sulfamethoxazole (2/38–4/76 mg/
L). The CLSI interpretive criteria were employed for each
antibacterial agent [5]. Quality control was conducted by using
E. coli ATCC 25922 and E. coli ATCC 35218.
Phenotypic Detection of AmpC b-lactamases and
Extended-spectrum b-lactamases
According to the characteristics of b-lactamase production,
AmpC-producing stains with a zone diameter #14 mm for
cefoxitin were classified as derepressed AmpC mutants when the
zone diameter was #17 mm for cefpodoxime/clavulanic acid,
while inducible AmpC-producing strains had a zone $18 mm for
cefpodoxime/clavulanic acid and a positive cefoxitin/cefpodoxime
antagonism test [7,11]. Possible ESBL-producing strains were
screened by a zone diameter #20 mm for cefpodoxime, followed
by the CLSI confirmatory test for ESBLs using disks of ceftazidime
(30 mg), cefotaxime (30 mg), and cefpodoxime (10 mg) with or
without clavulanic acid (10 mg) [5]. The boronic acid disk test was
also performed to detect ESBL production using disks with 400 mg
of boronic acid, as described previously [11]. A $5 mm increase
Table 1. Distribution of antimicrobial resistance genes among ESBL-producing Enterobacter spp.
b-lactamases PMQR determinants
ESBL-producing
Enterobacter spp. (n)
Inducible
AmpC
Derepressed
AmpC CTX-M-2 CTX-M-3 TEM-1 SHV-12 qnrA* qnrB qnrC qnrS qepA aac(6’)-Ib-cr
E. cloacae ( 1 8 ) 1 1 6 0 7 9220 07 0 0
E. aerogenes ( 4 ) 1 3 2 0 1000 01 0 0
*All qnrA were qnrA1.
doi:10.1371/journal.pone.0037967.t001
Table 2. Profile of Enterobacter spp. carrying ESBL genes and results of the boronic acid disk test.
Strain
No. Sample Organism AmpC ESBL PMQR
PFGE
type MIC (mg/L)
ESBL confirmatory
test
CTX CAZ FOX FEP MEM LVX AMK without BA with BA
A33 pus E. aerogenes derepressed CTX-M-2 not
detected
EA1 $128 $128 $64 32 2 1 #8 positive positive
D35 urine E. cloacae derepressed SHV-12 qnrA1 EC3 $128 $128 $64 $64 8 16 16 positive positive
F8 pus E. aerogenes inducible CTX-M-2 qnrS EA2 $128 8 $64 $64 1 1 #8 positive positive
F10 sputum E. cloacae inducible CTX-M-3 qnrS EC4 $128 8 $64 $64 #0.5 8 #8 positive positive
F22 sputum E. cloacae derepressed CTX-M-3 qnrS EC1 $128 $128 $64 $64 2 16 #8 negative positive
F25 sputum E. cloacae derepressed CTX-M-3 qnrS EC1 $128 $128 $64 $64 2 16 #8 negative positive
F33 sputum E. cloacae derepressed CTX-M-3 qnrS EC1 $128 $128 $64 $64 1 16 #8 negative positive
F38 sputum E. cloacae derepressed CTX-M-3 qnrS EC1 $128 $128 $64 $64 2 16 #8 negative positive
F43 sputum E. cloacae derepressed CTX-M-3 qnrS EC2 $128 64 $64 $64 #0.5 16 #8 negative positive
F46 pus E. cloacae derepressed CTX-M-3 qnrS EC1 $128 $128 $64 $64 1 8 #8 Negative positive
I62 urine E. cloacae derepressed SHV-12 qnrA1 EC3 $128 $128 $64 32 2 2 #8 Positive positive
CTX: cefotaxime, CAZ: ceftazidime, FOX: cefoxitin, FEP: cefepime, MEM: meropenem, LVX: levofloxacin, AMK: amikacin, BA: 3-aminophenylboronic acid. EC: Enterobacter
cloacae,E A :Enterobacter aerogenes.
doi:10.1371/journal.pone.0037967.t002
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indicated the presence of ESBLs.
ESBL and PMQR Gene Detection and Sequencing
PCR was performed to identify various resistance genes,
including b-lactamase genes (blaTEM, blaSHV and blaCTX-M),
PMQR genes (qnrA, qnrB, qnrC, qnrS, and qepA), and aac(6’)-Ib
[12,13,14]. For CTX-M positive strains, the CTX-M group was
determined by PCR using CTX-M-1, CTX-M-2, and CTX-M-9
group-specific primers [15,16,17]. For positive controls, we used
DNA extracts from clinical isolates which were confirmed to
possess b-lactamase or PMQR genes by sequencing. PCR
products were purified by using a QIA quick PCR Purification
Kit (Qiagen K. K., Tokyo, Japan), and then were sequenced by
using specific primers [14,15,16,17] with an ABI BigDye
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems,
Foster City, CA) on an ABI 37306l Analyzer (Applied Biosys-
tems). Sequencing data were analyzed with BLAST version 2.2.24
(http://blast.ddbj.nig.ac.jp/top-j.html).
Pulsed-field Gel Electrophoresis
For 11 ESBL-producing isolates (nine isolates of E. cloacae and
two isolates of E. aerogenes) in which blaCTX-M, blaSHV,o rblaTEM
were identified by PCR, evaluation of chromosomal polymor-
phisms was done by pulsed-field gel electrophoresis (PFGE) using
the XbaI restriction enzyme (Takara Bio Inc., Otsu, Japan), as
described previously [18]. Electrophoresis was performed on 1%
PFGE agarose gel with a CHEF-DR III system (Bio-Rad
Laboratories, Richmond, CA, USA). Electrophoretic patterns
were analyzed with GelCompar II version 3.0 (Applied Maths,
Kortrijik, Belgium). Similarity between two tracks was calculated
by using the coefficient of Jaccard and the band positions. Cluster
analysis was performed by the unweighted pair-group method
using arithmetic averages, and a dendrogram was generated by the
software. Isolates with $80% similarity were considered to reside
within a single cluster.
Statistical Analysis
Statistical analysis was conducted with the chi-square test or
Fisher’s test. A P value of less than 0.05 was considered significant.
Results and Discussion
A total of 206 (90.4%) of the 228 isolates of E. cloacae and 130
(95.6%) of the 136 isolates of E. aerogenes were phenotypically
confirmed to be AmpC producers. Among the 228 E. cloacae
isolates, there were 60 derepressed AmpC mutants (26.3%) and
146 inducible AmpC producers (64%), while the 136 E. aerogenes
isolates included 21 derepressed AmpC mutants (15.4%) and 109
inducible AmpC producers (80.1%). We found that 18 (7.9%) of
the 228 isolates of E. cloacae and 4 (2.9%) of the 136 isolates of E.
aerogenes were positive in the ESBL confirmatory test. All of the
ESBL-producing isolates, except one E. cloacae isolate, also
produced AmpC b-lactamases. In Osaka prefecture, the preva-
lence of ESBL-producing E. cloacae (8/35) was significantly higher
than that for all of Japan (18/228) (P,0.05). The prevalence of
ESBL-producing Enterobacter spp. varies among countries and
regions, as well as between detection methods. It was previously
Figure 1. Dendrogram and PFGE of XbaI-digested genomic DNAs from ESBL-producing Enterobacter species. EC: Enterobacter cloacae,
EA: Enterobacter aerogenes. Strain No. and PFGE type correspond to those in Table 2.
doi:10.1371/journal.pone.0037967.g001
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17.7% in Algeria [19], 28% in Taiwan [20], and 35.4% in Korea
[21]. Our data suggest that although the prevalence of ESBL-
producing E. cloacae in Japan is still lower than in those countries,
nevertheless the spread of ESBL-producers is certainly occurring
at large in our country.
Of the 22 ESBL producers, 16 isolates (72.7%) were only
detected by the CLSI confirmatory test, while six isolates (27.3%)
met the criteria for ESBL production in the boronic acid test.
Jeong et al. reported that the CLSI confirmatory test only detected
72.1% of ESBL producers, while the boronic acid disk test
detected 98.4% and showed no false-positive results [7]. In the
present study, the boronic acid disk test was useful for detecting
ESBL producers among chromosomal AmpC-producing Entero-
bacter spp.
All of the ESBL-producing Enterobacter spp. were resistant to
ampicillin and piperacillin. Nineteen isolates (86.4%) and 22
isolates (100%) were resistant to piperacillin-tazobactam and
cefoxitin, respectively, suggesting a high prevalence of AmpC b-
lactamases among ESBL producers. Resistance to cefpodoxime,
cefotaxime, ceftazidime, cefepime, and meropenem was shown by
22 (100%), 22 (100%), 20 (90.9%), 13 (59.1%), and 0 of these
isolates, respectively. Thus, carbapenem may be the most effective
treatment for ESBL-producing Enterobacter spp. Thirteen isolates
(59.1%) and 21 isolates (95.5%) were susceptible to gentamicin
and amikacin, respectively. Of the 10 qnr-positive isolates, 8 (80%)
were resistant to both ciprofloxacin and levofloxacin, while only
one (8.3%) of the 12 qnr-negative isolates was resistant to both
ciprofloxacin and levofloxacin (P,0.01). qnr determinants can
confer weak quinolone resistance [22]. There is concern that
Enterobacteriaceae possessing qnr and lacking sufficient chromo-
somal quinolone resistance could be classified as susceptible to
fluoroquinolones according to the CLSI criteria.
The distribution of antimicrobial resistance genes among ESBL-
producing Enterobacter spp. is summarized in Table 1. Of the 22
ESBL-producing strains, nine were positive for CTX-M, two for
SHV, and 10 for TEM by PCR. Sequencing revealed that seven of
the 20 isolates of E. cloacae had CTX-M-3, suggesting that it is
predominant among E. cloacae in Japan. An outbreak of CTX-M-
3-producing E. cloacae infection arising from a patient with
immature teratoma in the pediatric ward of a university hospital
in Osaka prefecture has been described previously [2]. Two of the
four isolates of E. aerogenes produced CTX-M-2. To our
knowledge, this is the first report of CTX-M-2 among E. aerogenes
in Japan. Both of the two SHV-positive isolates and all 10 TEM-
positive isolates had SHV-12 and TEM-1, respectively.
Of the 22 ESBL-producing strains, 10 were positive for PMQR
determinants (45.5%). Of the 10 isolates possessing PMQR genes,
eight and two were positive for qnrS and qnrA, respectively. This is
also the first report about qnr determinants among ESBL-
producing Enterobacter spp. from Japan. The profile of Enterobacter
spp. carrying ESBL genes is shown in Table 2. All seven of the
CTX-M-3-producing E. cloacae strains had qnrS, and qnrS positivity
was significantly more common among CTX-M-3-producing E.
cloacae (7/7) compared with other ESBL producers (7/7 vs. 1/4,
P,0.05). Both of the two SHV-12-producing E. cloacae possessed
qnrA1. None of the 22 ESBL-producing Enterobacter spp. had qnrB,
qnrC, qepA, and aac(6’)-Ib-cr. An association of PMQR determi-
nants with ESBLs has been reported by several authors. Park et al.
reported a high prevalence of qnrA and qnrB among ESBL-
producing E. cloacae in Korea [23], while there was a close
association of qnrA, qnrB,o rqnrS with SHV-12 production by E.
cloacae in France, Algeria, and Taiwan [19,20,24]. An association
of qnrB or qnrS with CTX-M-15 production by E. cloacae was also
reported in Algeria [19].
Of the 22 ESBL-producing isolates which were phenotipically
identified by disk tests, 11 isolates (nine for E. cloacae and two for E.
aerogenes) possessed ESBL genes (blaCTX-M-2, blaCTX-M-3,o rblaSHV-
12), but the remaining 11 isolates did not. Dissociation between
disk tests and PCR detection results can occur since screening
criteria for detection of ESBLs are not standardized for Enterobacter
spp. Therefore, we focused on 11 isolates in which ESBL genes
were identified by PCR and performed PFGE for them. Figure 1
shows dendrogram and PFGE of XbaI-digested genomic DNAs
from 11 ESBL-producing Enterobacter spp. The 11 ESBL-produc-
ing isolates possessing blaCTX-M, blaSHV,o rblaTEM were divided
into six unique PFGE types. Of seven isolates possessing blaCTX-M-
3 and qnrS from Osaka, five had identical PFGE type (EC1), while
two had different types (EC2 and EC4). Two isolates possessing
both blaSHV-12 and qnrA1 from Tokyo and Fukuoka were identical
cluster (EC3). These results suggest that E. cloacae harbouring both
blaCTX-M-3 and qnrS or both blaSHV-12 and qnrA1 are spreading via
plasmids or transposons in Japan, although a limitation of our
study is the relatively small sample size. Careful and continuous
monitoring of antimicrobial resistance among Enterobacter spp. is
needed.
Acknowledgments
We thank clinical laboratory technologists for their assistance in this study.
Author Contributions
Conceived and designed the experiments: H. Kanamori HY YH M. Kaku.
Performed the experiments: H. Kanamori HY AH KA SI MO MS.
Analyzed the data: H. Kanamori HY SE TA MH MY YG KT H.
Kunishima. Contributed reagents/materials/analysis tools: H. Kanamori
HY SI MO MS M. Kitagawa. Wrote the paper: H. Kanamori HY.
References
1. Dalben M, Varkulja G, Basso M, Krebs VL, Gibelli MA, et al. (2008)
Investigation of an outbreak of Enterobacter cloacae in a neonatal unit and review of
the literature. J Hosp Infect 70: 7–14.
2. Moriguchi N, Itahashi Y, Tabata N, Yamazumi T, Furuta I, et al. (2007)
Outbreak of CTX-M-3-type extended-spectrum b-lactamase-producing Entero-
bacter cloacae in a pediatric ward. J Infect Chemother 13: 263–266.
3. Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, et al.
(2011) Risk factors and outcome of extended-spectrum b-lactamase-producing
Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 37: 26–32.
4. Pitout JD, Laupland KB (2008) Extended-spectrum b-lactamase-producing
Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:
159–166.
5. CLSI (2010) Performance standards for antimicrobial susceptibility testing;
Twentieth informational supplement M100-S20. Clinical and Laboratory
Standards Institute, Wayne, PA, USA.
6. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, et al. (1983)
The inhibition of class C b-lactamases by boronic acids. Biochem J 209: 229–
233.
7. Jeong SH, Song W, Park MJ, Kim JS, Kim HS, et al. (2008) Boronic acid disk
tests for identification of extended-spectrum b-lactamase production in clinical
isolates of Enterobacteriaceae producing chromosomal AmpC b-lactamases.
Int J Antimicrob Agents 31: 467–471.
8. Robicsek A, Jacoby GA, Hooper DC (2006) The worldwide emergence of
plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629–640.
9. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmid-mediated
quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22: 664–689.
10. CLSI (2009) Methods for Dilution Antimicrobial Susceptibility Tests for
Bacteria That Grow Aerobically; Approved Standard-Eighth Edition M07-A8.
Clinical and Laboratory Standards Institute, Wayne, PA, USA.
11. Kanamori H, Yano H, Hirakata Y, Endo S, Arai K, et al. (2011) High
prevalence of extended-spectrum b-lactamases and qnr determinants in Citrobacter
ESBL and qnr in Enterobacter spp. from Japan
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e37967species from Japan: dissemination of CTX-M-2. J Antimicrob Chemother 66:
2255–2262.
12. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L (2003) Prevalence
and molecular epidemiology of CTX-M extended-spectrum b-lactamase-
producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.
Antimicrob Agents Chemother 47: 3724–3732.
13. Melano R, Corso A, Petroni A, Centro ´n D, Orman B, et al. (2003) Multiple
antibiotic-resistance mechanisms including a novel combination of extended-
spectrum b-lactamases in a Klebsiella pneumoniae clinical strain isolated in
Argentina. J Antimicrob Chemother 52: 36–42.
14. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, et al. (2009) Prevalence of
plasmid-mediated quinolone resistance determinants over a 9-year period.
Antimicrob Agents Chemother 53: 639–645.
15. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, et al. (2006)
Spread of blaCTX-M-type and blaPER-2 b-lactamase genes in clinical isolates from
Bolivian hospitals. J Antimicrob Chemother 57: 975–978.
16. Moubareck C, Daoud Z, Hakime ´ NI, Hamze ´ M, Mangeney N, et al. (2005)
Countrywide spread of community- and hospital-acquired extended-spectrum b-
lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin
Microbiol 43: 3309–3313.
17. Sabate ´ M, Tarrago ´ R, Navarro F, Miro ´ E, Verge ´s C, et al. (2000) Cloning and
sequence of the gene encoding a novel cefotaxime-hydrolyzing b-lactamase
(CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 44:
1970–1973.
18. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995)
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel
electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233–
2239.
19. Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, et al.
(2008) Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in
Algeria. J Antimicrob Chemother 62: 133–136.
20. Wu JJ, Ko WC, Tsai SH, Yan JJ (2007) Prevalence of plasmid-mediated
quinolone resistance determinants QnrA, QnrB, and QnrS among clinical
isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents
Chemother 51: 1223–1227.
21. Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, et al. (2005) Occurrence of extended-
spectrum b-lactamases among chromosomal AmpC-producing Enterobacter
cloacae, Citrobacter freundii,a n dSerratia marcescens in Korea and investigation of
screening criteria. Diagn Microbiol Infect Dis 51: 265–269.
22. Martinez-Martinez L, Pascual A, Jacoby GA (1998) Quinolone resistance from a
transferable plasmid. Lancet 351: 797–799.
23. Park YJ, Yu JK, Lee S, Oh EJ, Woo GJ (2007) Prevalence and diversity of qnr
alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter
freundii and Serratia marcescens: a multicentre study from Korea. J Antimicrob
Chemother 60: 868–871.
24. Cattoir V, Poirel L, Nordmann P (2007) Plasmid-mediated quinolone resistance
determinant QnrB4 identified in France in an Enterobacter cloacae clinical isolate
coexpressing a QnrS1 determinant. Antimicrob Agents Chemother 51: 2652–
2653.
ESBL and qnr in Enterobacter spp. from Japan
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37967